A new targeted chemotherapeutic nano-medicine NANOPt-pan, composed of Panitumumab and DACHPt (the active form of Oxaliplatin), could passively and actively target EGFR over-expressing tumors and effectively target both KRAS wild type- and mutant-tumors.
Cancer is a disease that is responsible for an overwhelming number of deaths worldwide. The conventional therapeutic approaches used for treatment can be ineffective. inducing prominent side effects.
Nanoparticles can assist in treatment of Head and Neck Cancer patients by optimizing distribution of chemotherapy drugs for better outcomes and less side effects.
A diverse range of nanomaterials with different physicochemical characteristics have been developed to stimulate the immune system and battle cancer.
Circulating tumor cells (CTCs) are stray cancer cells that shed from the primary cancer site and travel to healthy tissues and organs via the blood or lymphatic circulation. Once CTCs settle in their new location, they transform healthy cells around them into cancerous cells.
In a recent Review, a summary of 2D nanomaterials for used in cancer theranostics is provided.
Researchers have developed a controlled-release drug delivery system that uses focused ultrasound as an active induction method.
The fabrication of a specific nanomedicine, prickly shaped nanoparticles, enables a novel cancer treatment methodology.
Photothermal core-shell nanoparticles that can release nitric oxide upon NIR irradiation efficiently reversing multi-drug resistance in cancer.
Effect of low-dose exposure to bisphenol A on carcinogenesis of breast cancer.
New theory suggests gravity is not a fundamental force
Higgs boson may be driving the Universe’s expansion
Water-powered gadgets may be on the horizon thanks to new evaporation-based energy device
Scientists discover a new class of antibiotics
Micron-sized hidden dimensions could solve two of physics’ deepest puzzles
A new type of dark matter could explain mysterious radiation from the Milky Way’s core